Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Research (Washington, D.C.)|December 19, 2023
Dissection of FOXO1-Induced LYPLAL1-DT Impeding Triple-Negative Breast Cancer Progression via Mediating hnRNPK/β-Catenin ComplexYuhui Tang, Wenwen Tian, Shaoquan Zheng, et al.
Frontiers in Immunology|April 18, 2022
Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related SignatureYuhui Tang, Wenwen Tian, Jindong Xie, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 7, 2024
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancerYutian Zou, Anli Yang, Bo Chen, et al.
International Journal of Molecular Sciences|December 23, 2022
The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug ResistanceJindong Xie, Junsheng Zhang, Wenwen Tian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 29, 2024
Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast CancerWenwen Tian, Lewei Zhu, Yongzhou Luo, et al.
Cancer Research|September 12, 2025
circADAMTS12 Inhibits the Antitumor Activity of Microglia to Enable Metastatic Colonization in the BrainZhengmiao Xia, Weiguang Liu, Danni Guo, et al.
Medcomm|February 29, 2024
Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancerJindong Xie, Xinpei Deng, Yi Xie, et al.
Clinical and Translational Medicine|February 11, 2023
Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic studyShaoquan Zheng, Jie-Ying Liang, Yuhui Tang, et al.
International Journal of Surgery (London, England)|November 7, 2022
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgeryYutian Zou, Jindong Xie, Shaoquan Zheng, et al.
Oncoimmunology|January 10, 2022
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancerShaoquan Zheng, Yutian Zou, Yuhui Tang, et al.
Pageof 8